Peter Abbink

22PUBLICATIONS
155CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityVeterinary virologyAutonomic nervous systemInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 13, 2022
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial.

Boris Julg, Kathryn E Stephenson, Kshitij Wagh

|Oct 08, 2021
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.

Kathryn E Stephenson, Boris Julg, C Sabrina Tan

|Jun 25, 2021
Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and mice.

Rafael A Larocca, Peter Abbink, John D Ventura

|Mar 06, 2021
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques.

Anthony M Cadena, John D Ventura, Peter Abbink

|Feb 15, 2021
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.

Nadine C Salisch, Kathryn E Stephenson, Kristi Williams

|Oct 28, 2020
Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation.

Po-Ting Liu, Brandon F Keele, Peter Abbink

Pageof 4

Frequent Collaborators

13 joint publications

Dan H Barouch

7 joint publications

Noe Mercado

6 joint publications

Abishek Chandrashekar

5 joint publications

Rafael A Larocca